Population versus Customized Growth Curves: Prediction of Composite Neonatal Morbidity

Abstract

Objective To assess the ability of customized and population growth nomograms in identifying newborns with composite neonatal morbidity (CNM).

Study Design This study included women who participated in the 10 Maternal-Fetal Medicine Units (MFMU) trials and delivered a nonanomalous singleton with a known gestational age (GA) of 24 weeks or more and documented birthweight. Population nomograms were based on Alexander's nomogram, whereas customized nomograms used publicly available softwares. Random-effect logistic regression was used to estimate the adjusted odds ratio (aOR). Positive and negative likelihood ratios (LRs) were calculated to assess nomogram performance.

Results Of 92,225 women, 85% met the inclusion criteria. Using the population nomogram, 12% were small for gestational age (SGA) and 10% were large for gestational age (LGA), and using customized nomograms, 15% were SGA and 16% LGA. SGA newborns had a higher likelihood of CNM (aOR: 2.62; 95% confidence interval [CI]: 2.48–2.76) for population nomograms and 3.22 (95% CI: 3.07–3.39) for customized nomograms. LGA newborns had a similar CNM with population nomogram but significantly higher with customized nomogram (aOR: 1.42; 95% CI: 1.34–1.50). For the adverse outcomes among SGA and LGA, the positive LRs for the two nomograms were similar with overlapping 95% CI.

Conclusion Though both SGA and LGA are associated with adverse perinatal outcomes, the detection using both nomograms was similar.

Keywords

customized - population - neonatal morbidity

Note

This study was presented at the Society of Maternal-Fetal Medicine Annual Meeting in Las Vegas, NV, January 2017.

Condensation

Compared with population nomogram, customized growth nomogram has a slightly improved detection of the risk of stillbirth and neonatal morbidity/mortality.

• References

• 1 Boulet SL, Alexander GR, Salihu HM, Kirby RS, Carlo WA. Fetal growth risk curves: defining levels of fetal growth restriction by neonatal death risk. Am J Obstet Gynecol 2006; 195 (06) 1571-1577
• 2 Garite TJ, Clark R, Thorp JA. Intrauterine growth restriction increases morbidity and mortality among premature neonates. Am J Obstet Gynecol 2004; 191 (02) 481-487
• 3 McIntire DD, Bloom SL, Casey BM, Leveno KJ. Birth weight in relation to morbidity and mortality among newborn infants. N Engl J Med 1999; 340 (16) 1234-1238
• 4 Mendez-Figueroa H, Truong VT, Pedroza C, Khan AM, Chauhan SP. Small-for-gestational-age infants among uncomplicated pregnancies at term: a secondary analysis of 9 Maternal-Fetal Medicine Units Network studies. Am J Obstet Gynecol 2016; 215 (05) 628.e1-628.e7
• 5 Mendez-Figueroa H, Truong VT, Pedroza C, Chauhan SP. Morbidity and mortality in small-for-gestational-age infants: a secondary analysis of nine MFMU Network studies. Am J Perinatol 2017; 34 (04) 323-332
• 6 Chen HY, Chauhan SP, Ward TC, Mori N, Gass ET, Cisler RA. Aberrant fetal growth and early, late, and postneonatal mortality: an analysis of Milwaukee births, 1996-2007. Am J Obstet Gynecol 2011; 204 (03) 261.e1-261.e10
• 7 Mendez-Figueroa H, Truong VTT, Pedroza C, Chauhan SP. Large for gestational age infants and adverse outcomes among uncomplicated pregnancies at term. Am J Perinatol 2017; 34 (07) 655-662
• 8 Wilson TJ, Chang KW, Chauhan SP, Yang LJ. Peripartum and neonatal factors associated with the persistence of neonatal brachial plexus palsy at 1 year: a review of 382 cases. J Neurosurg Pediatr 2016; 17 (05) 618-624
• 9 Chauhan SP, Cole J, Laye MR. , et al. Shoulder dystocia with and without brachial plexus injury: experience from three centers. Am J Perinatol 2007; 24 (06) 365-371
• 10 Berkley E, Chauhan SP, Abuhamad A. ; Society for Maternal-Fetal Medicine Publications Committee. Doppler assessment of the fetus with intrauterine growth restriction. Am J Obstet Gynecol 2012; 206 (04) 300-308
• 11 American College of Obstetricians and Gynecologists' Committee on Practice Bulletins—Obstetrics. Practice Bulletin No. 173: fetal macrosomia. Obstet Gynecol 2016; 128 (05) e195-e209
• 12 Alexander GR, Himes JH, Kaufman RB, Mor J, Kogan M. A United States national reference for fetal growth. Obstet Gynecol 1996; 87 (02) 163-168
• 13 Duryea EL, Hawkins JS, McIntire DD, Casey BM, Leveno KJ. A revised birth weight reference for the United States. Obstet Gynecol 2014; 124 (01) 16-22
• 14 Gardosi J, Chang A, Kalyan B, Sahota D, Symonds EM. Customised antenatal growth charts. Lancet 1992; 339 (8788): 283-287
• 15 Gardosi J, Francis A. Adverse pregnancy outcome and association with small for gestational age birthweight by customized and population-based percentiles. Am J Obstet Gynecol 2009; 201 (01) 28.e1-28.e8
• 16 Chiossi G, Pedroza C, Costantine MM, Truong VTT, Gargano G, Saade GR. Customized vs population-based growth charts to identify neonates at risk of adverse outcome: systematic review and Bayesian meta-analysis of observational studies. Ultrasound Obstet Gynecol 2017; 50 (02) 156-166
• 17 Sibai BM, Caritis SN, Thom E. , et al; The National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. Prevention of preeclampsia with low-dose aspirin in healthy, nulliparous pregnant women. N Engl J Med 1993; 329 (17) 1213-1218
• 18 Goldenberg RL, Mercer BM, Meis PJ, Copper RL, Das A, McNellis D. ; NICHD Maternal Fetal Medicine Units Network. The preterm prediction study: fetal fibronectin testing and spontaneous preterm birth. Obstet Gynecol 1996; 87 (5 Pt 1): 643-648
• 19 Caritis S, Sibai B, Hauth J. , et al; National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. Low-dose aspirin to prevent preeclampsia in women at high risk. N Engl J Med 1998; 338 (11) 701-705
• 20 Meis PJ, Klebanoff M, Thom E. , et al; National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate. N Engl J Med 2003; 348 (24) 2379-2385
• 21 Landon MB, Hauth JC, Leveno KJ. , et al; National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Maternal and perinatal outcomes associated with a trial of labor after prior cesarean delivery. N Engl J Med 2004; 351 (25) 2581-2589
• 22 Rouse DJ, Hirtz DG, Thom E. , et al; Eunice Kennedy Shriver NICHD Maternal-Fetal Medicine Units Network. A randomized, controlled trial of magnesium sulfate for the prevention of cerebral palsy. N Engl J Med 2008; 359 (09) 895-905
• 23 Wapner RJ, Sorokin Y, Thom EA. , et al; National Institute of Child Health and Human Development Maternal Fetal Medicine Units Network. Single versus weekly courses of antenatal corticosteroids: evaluation of safety and efficacy. Am J Obstet Gynecol 2006; 195 (03) 633-642
• 24 Dizon-Townson D, Miller C, Sibai B. , et al; National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. The relationship of the factor V Leiden mutation and pregnancy outcomes for mother and fetus. Obstet Gynecol 2005; 106 (03) 517-524
• 25 Owen J, Yost N, Berghella V. , et al; National Institute of Child Health and Human Development, Maternal-Fetal Medicine Units Network. Mid-trimester endovaginal sonography in women at high risk for spontaneous preterm birth. JAMA 2001; 286 (11) 1340-1348
• 26 Harper M, Thom E, Klebanoff MA. , et al; Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Omega-3 fatty acid supplementation to prevent recurrent preterm birth: a randomized controlled trial. Obstet Gynecol 2010; 115 (2 Pt 1): 234-242
• 27 Gardosi J, Francis A. A Customised Weight Centile Calculator. GROW v6.7.8.4
• 28 Gardosi J, Mongelli M, Wilcox M, Chang A. An adjustable fetal weight standard. Ultrasound Obstet Gynecol 1995; 6 (03) 168-174
• 29 Raghunathan T, Lepkowksi J, Van Hoewyk J, Solenbeger P. A multivariate technique for multiply imputing missing values using a sequence of regression models. Surv Methodol 2001; 27: 85-95
• 30 Rubin DB, Schenker N. Multiple imputation in health-care databases: an overview and some applications. Stat Med 1991; 10 (04) 585-598
• 31 von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP. ; STROBE Initiative. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet 2007; 370 (9596): 1453-1457
• 32 Jaeschke R, Guyatt GH, Sackett DL. Users' guides to the medical literature. III. How to use an article about a diagnostic test. B. What are the results and will they help me in caring for my patients? The Evidence-Based Medicine Working Group. JAMA 1994; 271 (09) 703-707
• 33 van Eerd EA, Roex AJ, Nikpoor P, Dekker GA. Adverse perinatal outcome and maternal risk factors in population versus customized defined SGA babies. J Matern Fetal Neonatal Med 2012; 25 (04) 369-373
• 34 Hemming K, Hutton JL, Bonellie S. A comparison of customized and population-based birth-weight standards: the influence of gestational age. Eur J Obstet Gynecol Reprod Biol 2009; 146 (01) 41-45
• 35 Smith NA, Bukowski R, Thomas AM, Cantonwine D, Zera C, Robinson JN. Identification of pathologically small fetuses using customized, ultrasound and population-based growth norms. Ultrasound Obstet Gynecol 2014; 44 (05) 595-599
• 36 González-González NL, González-Dávila E, Cabrera F. , et al. Application of customized birth weight curves in the assessment of perinatal outcomes in infants of diabetic mothers. Fetal Diagn Ther 2015; 37 (02) 117-122
• 37 Kase BA, Carreno CA, Blackwell SC. Customized estimated fetal weight: a novel antenatal tool to diagnose abnormal fetal growth. Am J Obstet Gynecol 2012; 207 (03) 218.e1-218.e5